Healthcare / Medical Care FacilitiesSES
$0.08
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.9M · quality 66.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$13M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-21.8%
↓Gross Margin
N/A
•Debt/Equity
0.60
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
-0.24x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $-4.0M · FCF $965000.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | — | — | $26.9M | $22.1M | $18.8M | $11.0M |
| Net Income | $-4.0M | $-4.0M | $2.0M | $-666000.00 | $3.9M | — |
| EBITDA | $-601000.00 | $-601000.00 | $5.9M | $3.2M | $6.5M | — |
| EPS | -0.02 | -0.02 | 0.01 | -0.00 | 0.02 | — |
| Gross Margin | — | — | 80.7% | 82.8% | 83.2% | 79.1% |
| Operating Margin | — | — | 22.9% | 31.2% | 40.2% | — |
| Net Margin | — | — | 7.3% | -3.0% | 20.7% | — |
| Balance Sheet | ||||||
| Debt/Equity | 0.60 | 0.60 | 0.51 | 0.59 | 0.31 | — |
| Current Ratio | 1.29 | 1.29 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $965000.00 | $965000.00 | $2.9M | $3.7M | $5.9M | — |
| Returns | ||||||
| ROE | -21.8% | -21.8% | 8.7% | -3.2% | 15.2% | — |
| Valuation | ||||||
| P/B | 0.70 | 0.70 | — | — | — | — |
| Growth & Yield | ||||||
| Revenue Growth | — | — | 21.9% | 17.2% | 71.9% | — |
| EPS Growth | -305.2% | -305.2% | 394.9% | -118.0% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-51.6%
Start / end P/E
n/dx → n/dx
EPS bridge
0.01 → -0.02
Residual
-51.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.